Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization

J Investig Allergol Clin Immunol. 2024 Jun;34(3):214-216. doi: 10.18176/jiaci.0990.
No abstract available

Keywords: Anaphylaxis; Desensitization; Isatuximab; Systemic mastocytosis.

Publication types

  • Case Reports

MeSH terms

  • Anaphylaxis* / diagnosis
  • Anaphylaxis* / etiology
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Desensitization, Immunologic* / methods
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / etiology
  • Humans
  • Mastocytosis, Systemic* / complications
  • Mastocytosis, Systemic* / diagnosis
  • Mastocytosis, Systemic* / drug therapy
  • Mastocytosis, Systemic* / immunology
  • Multiple Myeloma* / complications
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / immunology

Substances

  • Antibodies, Monoclonal, Humanized
  • isatuximab